FindTrial
Sign In

Risk assessment and early risk predictors of bacterial infections in children undergoing cancer treatment.

Risk factors for early prediction of bacterial infections in children with febrile neutropenia. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/10/058866
Enrollment
117
Registered
2023-10-19
Start date
Unknown
Completion date
Unknown
Last updated
2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D709- Neutropenia, unspecified

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Dr Esha P Suresh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Children

Exclusion criteria

Exclusion criteria: Children whose parents refuse to participate in the study and children with underlying syndromes and primary immunodeficiency.

Design outcomes

Primary

MeasureTime frame
To be able to predict the risk factors (IL6,CRP,CBC,PCT,RFT,LFT,Blood culture sensitivity) for early detection of bacterial infection in children with febrile neutropenia using the available variables. It will be assessed over a course of 1 week.Timepoint: Assessed at baseline and at the end of 1 week.—

Secondary

MeasureTime frame
To study the delay & dose variations in chemotherapy due to febrile neutropenic episodes. To study the need for reserved antibiotic use.Timepoint: Assessed at baseline & at the end of 1 week—

Countries

India

Contacts

Public ContactDr Esha P Suresh

Kasturba Medical College, Manipal

kumar.sandeep@manipal.edu8197120018

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026